Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Brieghel

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Hemasphere|March 20, 2024
Mortality in patients with lymphoid malignancies and multiple myeloma was stable upon and during the COVID-19 pandemic: A population-based, nation-wide studyTereza Faitová, Christian Brieghel, Frank Eriksson, et al.
Blood Advances|April 25, 2022
Prediction of clinical outcome in CLL based on recurrent gene mutations, CLL-IPI variables, and (para)clinical dataMehdi Parviz, Christian Brieghel, Rudi Agius, et al.
Hemoglobin|June 27, 2015
Novel 31.2 kb α0 Deletion in a Palestinian Family with α-ThalassemiaChristian Brieghel, Henrik Birgens, Henrik Frederiksen, et al.
Blood Advances|May 13, 2026
Rituximab maintenance after first-line rituximab-bendamustineChristian Brieghel, Mikkel Werling, Peter de Nully Brown, et al.
Blood Advances|March 1, 2024
It is feasible and safe to stop specialized follow-up of asymptomatic lower-risk chronic lymphocytic leukemiaChristian Brieghel, Caspar da Cunha-Bang, Jindrich Mourek, et al.
Blood Advances|January 28, 2022
CLL-IPI applied in Binet A CLL: a nationwide cohort studyEmelie C Rotbain, Caspar da Cunha-Bang, Christian Brieghel, et al.
Haematologica|October 17, 2024
Frequency of secondary T-cell lymphoma in chimeric antigen receptor T-cell naïve B-cell lymphoid-lineage cancers is higher than that reported on chimeric antigen receptor T-cell therapyChristian Brieghel, Søren L Petersen, Peter de N Brown, et al.
Blood|May 19, 2022
Patients with CLL have a lower risk of death from COVID-19 in the Omicron eraCarsten U Niemann, Caspar da Cunha-Bang, Marie Helleberg, et al.
Ejhaem|July 18, 2022
Facilitating EMA binding test performance using fluorescent beads combined with next-generation sequencingAndreas Glenthøj, Christian Brieghel, Amina Nardo-Marino, et al.
Blood Cancer Journal|April 8, 2025
A Real-World International Staging System (RW-ISS) for patients with newly diagnosed multiple myelomaChristian Brieghel, Tobias Schmidt Slørdahl, Morten Nørgaard Andersen, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Hemasphere|March 20, 2024
Mortality in patients with lymphoid malignancies and multiple myeloma was stable upon and during the COVID-19 pandemic: A population-based, nation-wide studyTereza Faitová, Christian Brieghel, Frank Eriksson, et al.
Blood Advances|April 25, 2022
Prediction of clinical outcome in CLL based on recurrent gene mutations, CLL-IPI variables, and (para)clinical dataMehdi Parviz, Christian Brieghel, Rudi Agius, et al.
Hemoglobin|June 27, 2015
Novel 31.2 kb α0 Deletion in a Palestinian Family with α-ThalassemiaChristian Brieghel, Henrik Birgens, Henrik Frederiksen, et al.
Blood Advances|May 13, 2026
Rituximab maintenance after first-line rituximab-bendamustineChristian Brieghel, Mikkel Werling, Peter de Nully Brown, et al.
Blood Advances|March 1, 2024
It is feasible and safe to stop specialized follow-up of asymptomatic lower-risk chronic lymphocytic leukemiaChristian Brieghel, Caspar da Cunha-Bang, Jindrich Mourek, et al.
Blood Advances|January 28, 2022
CLL-IPI applied in Binet A CLL: a nationwide cohort studyEmelie C Rotbain, Caspar da Cunha-Bang, Christian Brieghel, et al.
Haematologica|October 17, 2024
Frequency of secondary T-cell lymphoma in chimeric antigen receptor T-cell naïve B-cell lymphoid-lineage cancers is higher than that reported on chimeric antigen receptor T-cell therapyChristian Brieghel, Søren L Petersen, Peter de N Brown, et al.
Blood|May 19, 2022
Patients with CLL have a lower risk of death from COVID-19 in the Omicron eraCarsten U Niemann, Caspar da Cunha-Bang, Marie Helleberg, et al.
Ejhaem|July 18, 2022
Facilitating EMA binding test performance using fluorescent beads combined with next-generation sequencingAndreas Glenthøj, Christian Brieghel, Amina Nardo-Marino, et al.
Blood Cancer Journal|April 8, 2025
A Real-World International Staging System (RW-ISS) for patients with newly diagnosed multiple myelomaChristian Brieghel, Tobias Schmidt Slørdahl, Morten Nørgaard Andersen, et al.
Pageof 6